Continue reading this on our app for a better experience

Open in App
Floating Button

ISEC Healthcare share sale agreement set to trigger 36 cts/share offer when completed

PC Lee
PC Lee • 1 min read
ISEC Healthcare share sale agreement set to trigger 36 cts/share offer when completed
SINGAPORE (Aug 27): ISEC Healthcare, the provider of medical eyecare, has entered into a sale and purchase agreement that when completed, will trigger a mandatory general offer for the remaining shares.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Aug 27): ISEC Healthcare, the provider of medical eyecare, has entered into a sale and purchase agreement that when completed, will trigger a mandatory general offer for the remaining shares.

In a Monday evening filing, ISEC Healthcare announced Aier Eye International had agreed to buy about 186.3 million ISEC Healthcare shares for 36 cents each, valuing the deal at $67.1 million in total.

When the transaction is completed, Aier Eye International will own 35% of ISEC Healthcare, triggering the mandatory general offer for the remaing shares at the same price of 36 cents.

The offer price is 5.88% more than the closing price of 34 cents on June 28, the last trading day before a trading halt was called.

Aier Eye International is a direct wholly owned subsidiary of China-incorporated Aier Eye Hospital Group.

Aier Eye International has cited ISEC Healthcare's low historical trading liquidity as a reason for the offer.

In 2Q ended June, ISEC Healthcare reported earnings almost halved to $1.1 million, from $2.2 million a year ago despite revenue being up 1% to $10.5 million.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.